Bejerano, Maricel Sofia N.

HRN: 01-66-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFUROXIME 1.5GM (VIAL)
06/23/2025
06/24/2025
IV
1.5g
Q8hrs
S/P LSTCS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: